investigated the therapeutic potential of S100A8/A9 blockade in the context of sepsis-induced myocardial dysfunction, highlighting the critical role of S100A8/A9 in mediating both myocardial and systemic inflammation in sepsis. The gene discussed is S100A8; the disease is Sepsis.